Treatment | N | Î’ | P value | 95% CI |
---|---|---|---|---|
Pain VAS score | ||||
  Glucosamine | 195 | −1.75 | 0.034* | −3.32, −0.17 |
  NSAIDs | 292 | −1.74 | 0.047* | −3.44, −0.03 |
  Diacerein | 209 | −1.78 | 0.024* | −3.24, −0.32 |
  Placebo | 187 | 0 | - | - |
  Diacerein vs. glucosamine | - | −0.03 | 0.964 | −1.58, 1.52 |
  NSAIDs vs. glucosamine | - | 0.01 | 0.988 | −1.52, 1.54 |
  Diacerein vs. NSAIDs | - | −0.04 | 0.893 | −0.72, 0.64 |
Total WOMAC score | ||||
  Glucosamine | 73 | 17.70 | 0.367 | −35.46, 70.87 |
  NSAIDs | 79 | −7.03 | 0.334 | −26.51, 12.45 |
  Diacerein | 164 | −6.2 | 0.597 | −39.69, 27.29 |
  Placebo | 159 | 0 | - | - |
  Diacerein vs. glucosamine | - | −23.90 | 0.218 | −72.85, 25.06 |
  NSAIDs vs. glucosamine | - | −24.74 | 0.180 | −69.91, 20.44 |
  Diacerein vs. NSAIDs | - | 0.84 | 0.899 | −18.52, 20.20 |
Pain WOMAC score | ||||
  Glucosamine | 408 | 1.47 | 0.139 | −0.74, 3.68 |
  NSAIDs | 164 | −0.38 | 0.612 | −2.31, 1.55 |
  Diacerein | 397 | −0.75 | 0.521 | −3.75, 2.24 |
  Placebo | 491 | 0 | - | - |
  Diacerein vs. glucosamine | - | −2.22 | 0.078 | −4.84, 0.39 |
  NSAIDs vs. glucosamine | - | −1.85 | 0.065 | −3.88, 0.18 |
  Diacerein vs. NSAIDs | - | −0.376 | 0.643 | −2.46, 1.71 |
Function WOMAC score | ||||
  Glucosamine | 408 | −2.42 | 0.534 | −11.18, 6.33 |
  NSAIDs | 503 | 1.53 | 0.463 | −3.13, 6.20 |
  Diacerein | 189 | 1.89 | 0.392 | −3.02, 6.81 |
  Placebo | 407 | 0 | - | - |
  Diacerein vs. glucosamine | - | 4.32 | 0.436 | −8.03, 16.67 |
  NSAIDs vs. glucosamine | - | 3.96 | 0.438 | −7.43, 15.34 |
  Diacerein vs. NSAIDs | - | 0.36 | 0.913 | −7.16, 7.89 |
Stiffness WOMAC score | ||||
  Glucosamine | 390 | −0.15 | 0.480 | −0.66, 0.36 |
  NSAIDs | 397 | −0.77 | 0.207 | −2.14, 0.60 |
  Diacerein | 196 | −0.89 | 0.097 | −2.01, 0.23 |
  Placebo | 499 | 0 | - | - |
  Diacerein vs. glucosamine | - | −0.74 | 0.193 | 2.00, −0.52 |
  NSAIDs vs. glucosamine | - | 0.62 | 0.205 | −1.71, 0.47 |
  Diacerein vs. NSAIDs | - | −0.12 | 0.788 | −1.20, 0.96 |
Lequesne score change | ||||
  Glucosamine | 214 | −1.12 | 0.063 | −2.36, 0.12 |
  Diacerein | 75 | 0.03 | 0.970 | −2.13, 2.18 |
  Placebo | 192 | 0 | - | - |
  Diacerein vs. glucosamine | - | 1.15 | 0.331 | −4.32, 2.01 |
Joint space width change | ||||
  Glucosamine | 357 | −0.08 | 0.363 | −0.31, 0.14 |
  Diacerein | 246 | 0.12 | 0.207 | −0.10, 0.34 |
  Placebo | 597 | 0 | - | - |
  Diacerein vs. glucosamine | - | −0.20 | 0.001* | −0.27, −0.14 |
Adverse event | N | RR | P value | 95% CI |
  Glucosamine | 1,474 | 1.07 | 0.398 | 0.92, 1.23 |
  NSAIDs | 814 | 2.20 | <0.001* | 1.56, 3.11 |
  Diacerein | 381 | 1.91 | <0.001* | 1.36, 2.69 |
  Placebo | 1,634 | 1 | - | - |
  Diacerein vs. glucosamine | - | 1.80 | 0.001* | 1.27, 2.55 |
  NSAIDs vs. glucosamine | - | 2.07 | <0.001* | 1.47, 2.91 |
  Diacerein vs. NSAIDs | - | 0.87 | 0.416 | 0.62, 1.22 |
Adverse event (GI) | ||||
  Glucosamine | 1,850 | 0.84 | 0.103 | 0.68, 1.04 |
  NSAIDs | 899 | 1.33 | 0.038* | 1.02, 1.77 |
  Diacerein | 1,345 | 1.44 | <0.001* | 1.24, 1.68 |
  Placebo | 1,917 | 1 | - | - |
  Diacerein vs. glucosamine | - | 1.72 | <0.001* | 1.34, 2.22 |
  NSAIDs vs. glucosamine | - | 1.60 | 0.004* | 1.16, 2.19 |
  Diacerein vs. NSAIDs | - | 1.08 | 0.576 | 0.98, 1.50 |